CRISPR Therapeutics AG

AI Score

XX

Unlock

32.67
-1.52 (-4.45%)
At close: Apr 03, 2025, 3:59 PM
32.63
-0.12%
After-hours: Apr 03, 2025, 07:59 PM EDT

CRISPR Therapeutics AG Stock Forecast

Stock Price Forecast

The 19 analysts with 12-month price forecasts for CRSP stock have an median target of 82, with a low estimate of 32 and a high estimate of 120. The median target predicts an increase of 150.99% from the current stock price of 32.67.

Target Low Average Median High
Price $32 $74.35 $82 $120
Change -2.05% 127.58% 150.99% 267.31%

Latest Analyst Insight Report

Chardan Capital maintains a Buy rating on CRISPR T... Unlock content with Pro Subscription

Updated Feb 13, 2025

Rating Aug 24Oct 24Nov 24Dec 24Jan 25Feb 25
Strong Buy 000001
Buy 301227
Hold 412005
Sell 000001
Strong Sell 000000
Total 7 1 3 2 2 14

Financial Forecast this Year

Revenue This Year
58.51M
from 35M
Increased by 67.2%
Revenue Next Year
217.49M
from 58.51M
Increased by 271.7%
EPS This Year
-4.81
from -4.34
Increased by -10.8%
EPS Next Year
-4.05
from -4.81
Increased by 15.8%